Close

Eli Lilly & Co. (LLY), Sanford-Burnham to Collaborat on Immunotherapies

May 14, 2015 6:14 AM EDT Send to a Friend
Eli Lilly & Co. (NYSE: LLY) and Sanford-Burnham Medical Research Institute today announced that they will collaborate to discover and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login